FIGHT KIDS CANCER

This is one of the achievements we are most proud of.

FIGHT KIDS CANCER is a joint initiative by KickCancer, Imagine for Margo (France) and the Fondatioun Kriibskrank Kanner (Luxembourg), the aim of which is to accelerate the most innovative treatments thanks to European financing and collaboration of research on paediatric cancers. FIGHT KIDS CANCER entails the launch of recurring annual calls for projects. Since 2020 we have invested a total of 12,25 million euros, of which 2,5 million euros are funded by KickCancer.

In September 2022, we launched our fourth FIGHT KIDS CANCER call for projects for a total amount of 6,25 million euros of which KickCancer has the ambition to finance 1 million euros thanks to RUN TO KICK 2023.

In Belgium, France, Luxembourg and Spain as well as in other European countries in the future, those projects are indeed financed thanks to the organisation of our charity family races. When more runners participate or their motivation to fundraise increases, the amount we can invest in research follows suit.

Register today for RUN TO KICK 2023 by running, walking or donating to one of your friends that participate or by sponsoring us and shooting kids’ cancer forever away!

The third call led to the selection, by independent international experts, of seven innovative research projects of European scope for a total amount of 7,25 million euros of which KickCancer financed one million euro. Through these projects, we hope to foster improvements in the knowledge and treatment of the following diseases:

• Neuroblastoma (one clinical trial and two translational projects: n°1 & n°2);
• Leukaemia and lymphoma (one clinical trial);
• Leukaemia: two translational projects (one for acute lymphoblastic leukaemia and one for acute myeloid leukaemia);
• All tumours (one clinical trial).

In 2021, the second call led to the selection of five innovative projects for a total amount of 3,45 million euros, from which €725 000 were financed by KickCancer. These 5 projects are about the following diseases: B-cell non-Hodgkin's lymphoma, Ewing's sarcoma, medulloblastoma and neuroblastoma (2 projects: n°1 & n°2).

In 2020, the first call led to the selection of six innovative projects for a total amount of 3,08 million euros, from which €800 000 were financed by KickCancer. These 6 projects are about the following diseases: high-grade gliomas (2 projects: n°1 & n°2), acute myeloid leukaemia, rhabdoid tumours, osteosarcoma and neuroblastomas.